Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia

PHASE3CompletedINTERVENTIONAL
Enrollment

708

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

November 30, 2005

Study Completion Date

November 30, 2005

Conditions
Vascular Dementia
Interventions
DRUG

Rivastigmine

Trial Locations (63)

10003

New York

15601

Greensburg

18103

Allentown

29406

Charleston

33140

Miami Beach

33426

Boynton Beach

46202

Indianapolis

50314

Des Moines

77030

Houston

78756

Austin

92618

Irvine

94109

San Francisco

97223

Portland

Unknown

Port Charlotte

St Louis

Albuquerque

Graz

Linz

Vienna

Edmonton

Ottawa

Toronto

Montreal

Amiens

Bordeaux

Lille

Marseille

Montpellier

Toulouse

Tours

Bautzen

Berlin

Bochum

Chemnitz

Eisenhüttenstadt

Erlangen

Freiburg im Breisgau

Lüdenscheid

Osnabrück

Ancona

Brescia

Florence

Perugia

Reggio Emilia

Roma

Vicenza

Moscow

Saint Petersburg

Barakaldo

Barcelona

Madrid

Pamplona

Saint Cugat Del Valles

Basel

Lausanne

Newcastle upon Tyne

Swindon

Bristol

Clydebank

East Sussex

Lytham St Annes

Southampton

05201

Bennington

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY